This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mylan NV (MYL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 1.24B 225.50M 291.29M 349.97M
Receivables 2.69B 2.27B 1.82B 1.55B
Inventories 1.95B 1.65B 1.66B 1.53B
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 6.47B 6.79B 4.47B 3.90B
Property, Plant & Equipment, Gross 3.29B 2.96B 2.73B 2.48B
Accumulated Depreciation & Depletion 1.31B 1.17B 1.06B 1.09B
Property, Plant & Equipment, Net 1.98B 1.79B 1.66B 1.40B
Intangibles 7.22B 2.35B 2.34B 2.22B
Other Non-Current Assets 751.50M 834.20M 2.39B 804.20M
Total Non-Current Assets 15.79B 9.10B 10.77B 8.03B
Liabilities & Shareholder Equity
Total Assets 22.27B 15.89B 15.24B 11.93B
Accounts Payable 1.11B 905.60M 1.07B 777.91M
Short Term Debt 1.08B 2.81B 443.43M 397.04M
Other Current Liabilities 736.90M 533.10M 654.43M 1.02B
Total Current Liabilities 4.12B 5.31B 2.96B 2.19B
Long Term Debt 6.30B 5.73B 7.59B 5.34B
Deferred Income Taxes 718.10M 235.40M 468.53M 274.26M
Other Non-Current Liabilities 1.37B 1.34B 1.27B 0.00
Minority Interest 100.00K 3.70M 2.82M 2.08M
Total Non-Current Liabilities 8.38B 7.33B 9.34B 6.40B
Total Liabilities 12.50B 12.63B 12.29B 8.59B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 9.76B 3.26B 2.94B 3.34B
Common Par 5.50M 273.30M 271.99M 269.83M
Additional Paid In Capital 7.13B 4.21B 4.10B 3.99B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 4.46B 3.61B 2.69B 2.06B
Treasury Stock -67.50M -3.86B -3.88B -2.89B
Other Equity Adjustments -1.76B -987.00M -240.13M -86.50M
Total Capitalization 16.06B 8.99B 10.53B 8.68B
Total Equity 9.76B 3.26B 2.94B 3.34B
Total Liabilities & Stock Equity 22.27B 15.89B 15.24B 11.93B
Total Common Shares Outstanding 490.62M 375.22M 371.60M 395.21M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 1.31M 171.44M 172.37M 144.46M
Basic Weighted Shares Outstanding 472.20M 373.70M 383.33M 415.21M
Diluted Weighted Shares Outstanding 497.40M 398.00M 394.45M 420.24M
Number of Employees 35000 30000 20000 20000
Number of Part-Time Employees 0 0 0 0
MYL News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for MYL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 5 6 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MYL ANALYST REPORT

MYL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs